Ku, E.J.; Kim, B.-R.; Lee, J.-I.; Lee, Y.K.; Oh, T.J.; Jang, H.C.; Choi, S.H.
The Anti-Atherosclerosis Effect of Anakinra, a Recombinant Human Interleukin-1 Receptor Antagonist, in Apolipoprotein E Knockout Mice. Int. J. Mol. Sci. 2022, 23, 4906.
https://doi.org/10.3390/ijms23094906
AMA Style
Ku EJ, Kim B-R, Lee J-I, Lee YK, Oh TJ, Jang HC, Choi SH.
The Anti-Atherosclerosis Effect of Anakinra, a Recombinant Human Interleukin-1 Receptor Antagonist, in Apolipoprotein E Knockout Mice. International Journal of Molecular Sciences. 2022; 23(9):4906.
https://doi.org/10.3390/ijms23094906
Chicago/Turabian Style
Ku, Eu Jeong, Bo-Rahm Kim, Jee-In Lee, Yun Kyung Lee, Tae Jung Oh, Hak C. Jang, and Sung Hee Choi.
2022. "The Anti-Atherosclerosis Effect of Anakinra, a Recombinant Human Interleukin-1 Receptor Antagonist, in Apolipoprotein E Knockout Mice" International Journal of Molecular Sciences 23, no. 9: 4906.
https://doi.org/10.3390/ijms23094906
APA Style
Ku, E. J., Kim, B.-R., Lee, J.-I., Lee, Y. K., Oh, T. J., Jang, H. C., & Choi, S. H.
(2022). The Anti-Atherosclerosis Effect of Anakinra, a Recombinant Human Interleukin-1 Receptor Antagonist, in Apolipoprotein E Knockout Mice. International Journal of Molecular Sciences, 23(9), 4906.
https://doi.org/10.3390/ijms23094906